Contributors from the PKU community, including patient reps, key opinion leaders, and medical experts, discuss the implications of redefining ‘unmet medical need’ in the EU’s pharmaceutical legislation, emphasising the potential negative impact on patients, particularly those with rare diseases like phenylketonuria.
Gillian Molloy, Director of Market Access at AscellaHealth, examines the rare disease landscape in the UK, including progress in improving patient care and challenges in diagnostics and the development of new treatments.
A new policy brief from the European Observatory created with and for the Swedish Presidency of the Council of the EU details concrete steps for urgent action on AMR.
Polycystic kidney disease is a genetic disorder that lacks a cure and can significantly impact an individual’s quality of life. We spoke to the American Kidney Fund regarding the challenges of diagnosis and disease management.
Dr Avinash Hari Narayanan (MBChB), Clinical Lead at London Medical Laboratory, explores the key challenges in mesothelioma prevention, diagnosis and treatment.
Research conducted by the University of Surrey suggests that insulin icodec, a weekly basal injection, may be just as effective when treating type 1 diabetes compared to daily basal insulin treatments.
A study has revealed that a 1 % decrease in deep sleep each year among individuals aged 60 and older can lead to a 27 % rise in the risk of developing dementia.
UK-based charity, Epilepsy Action, outlines how glioma-related epilepsy can heavily impact a person’s quality of life, drawing on the need for further research and treatment options.
Researchers aim to uncover how extreme weather affects long-term HIV care outcomes and implications for addressing climate change impacts and other chronic health conditions.
In a groundbreaking collaboration, the Accelerated Capability Environment (ACE) has teamed up with the NHS's AI Skunkworks to harness AI to diagnose Parkinsons with unprecedented speed.
A new groundbreaking blood test, p-tau217, holds potential as an Alzheimer's disease indicator. When incorporated into a two-step process, it demonstrates exceptional accuracy in detecting or ruling out brain amyloidosis, a crucial early sign.
A new study of chronic fatigue syndrome reveals how women are more severely affected by the condition and tend to develop more severe symptoms over time.
